• Here’s why the QBE (ASX:QBE) share price is up 27% so far in 2021

    Young boy with glasses and grey long sleeved top looking pensive as if wondering about asx share price

    The QBE Insurance Group Ltd (ASX: QBE) share price continued its positive run yesterday, up another 1.41% to $10.78.

    This means the insurance group’s shares are now up 27% in 2021, reflecting optimistic investor sentiment.

    With no news out of the company, we take a closer look at what could be pushing QBE shares higher.

    QBE in recovery mode?

    A possible catalyst for the rise in QBE shares this year could be the release of the company’s annual general meeting (AGM) address to shareholders.

    During late April, QBE revealed the global economic outlook has improved, with growth expected to be at 6% this calendar year.

    This is a stark contrast to 2020, during which COVID-19, along with higher-than-normal catastrophe events around the world, impacted the business. QBE reported a disappointing statutory loss of US$1.5 billion for FY20.

    However, fast forward to FY21, the company stated that pricing momentum has accelerated, particularly in the northern hemisphere. QBE improved gross written premium (GWP) by 28% in the first quarter, compared to 23% in Q1 FY20 on a constant-currency basis. The increase reflected continued growth in select areas of QBE’s global portfolio coupled with a substantial uplift in crop premiums.

    Pleasingly, the company reported that the overall first-quarter combined operating ratio is in line with expectations. It further noted that the net cost of COVID-19 remains unchanged.

    In addition, QBE updated investors earlier this month in respect to a representative proceeding from Strand Fitness Pty Ltd “and others”.

    The allegations state that QBE Insurance Australia denied cover to certain policyholders during COVID-19 for losses from business interruption. QBE said the allegations will be defended, and that business interruption claims remain robust. Despite the reassurance, the QBE share price fell by 1.7% on the day of the update.

    What do the brokers think?

    A broker note from Macquarie two weeks ago advised the broker was raising its price target by 1% to $10.10 for QBE shares. Goldman Sachs and Citi followed suit but provided different outlooks.

    Both brokers increased their rating on QBE shares, adding 4.3% to $12.49, and 2.9% to $12.35, respectively. Based on the last closing price of the QBE share price, this implies an upside of around 15% to 16%.

    QBE share price snapshot

    QBE faced a turbulent couple of months during early 2021, with the company’s shares hitting a 52-week low of $7.88. Since then, the QBE share price has recovered to post a healthy gain of 27%. In comparison, the S&P/ASX 200 Financials Index (ASX: XFJ) is up roughly 18% year to date.

    QBE commands a market capitalisation of around $15.9 billion, making it the 28th largest company on the ASX.

    The post Here’s why the QBE (ASX:QBE) share price is up 27% so far in 2021 appeared first on The Motley Fool Australia.

    Should you invest $1,000 in QBE right now?

    Before you consider QBE, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and QBE wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3iJc2fq

  • Plumbing, health, tech: 3 ASX shares to buy for instant diversification

    The Montgomery Fund's Joseph Kim

    Ask A Fund Manager

    The Motley Fool chats with fund managers so that you can get an insight into how the professionals think. In this edition, The Montgomery Fund portfolio manager Joseph Kim tells how he sees value buys across many ASX sectors.

    Investment style

    The Motley Fool: How would you describe your fund to a potential client?

    Joseph Kim: We’re a well-diversified quality portfolio with a value lens.

    MF: What are your two biggest holdings?

    JK: It’s Commonwealth Bank of Australia (ASX: CBA) and Westpac Banking Corp (ASX: WBC) at the moment.

    MF: What are your two biggest active holdings?

    JK: Our biggest active holdings at the moment are Sydney Airport Holdings Pty Ltd (ASX: SYD) and Reliance Worldwide Corporation Ltd (ASX: RWC).

    So [Reliance] is a global producer of plumbing fixtures. Their main market is in the US but they also have operations in Australia and Europe. Their signature product is something called push-to-connect. When you have a pipe burst, you can quickly fix it — you’ve got this brass fitting, you put it in between and you click both ends of the pipe together. And you’ve got a seamless waterproof fixture, which doesn’t require a plumber to come in and solder or crimp.

    In the US, you can do your own plumbing… They’ve got this dominant market position — it’s called SharkBite. And the brand is synonymous with this push-to-connect product. 

    There’s enormous strength in that brand name. And the penetration is still fairly low. I think they’re about 15% to 20% penetration relative to solder, relative to crimp. You have this enormous market share potential over time because the plumbers use it and they recognise the time-saving benefits. 

    MF: What do you think of Sydney Airport after the recent acquisition offer?

    JK: If you look at where the share price is trading, it’s trading below the bid price. I think without that bid there… it’s likely that the share price will be lower than where it is at the moment. 

    So you’ve got to take that into account, but I think there’s an expectation that a lot of these big super funds have longer term time horizons. They’re not investing for 6 to 12 months, they’re investing for 20 to 30 years and you’re matching your liability stream. If you’re a super fund, it’s not about, “Well, what’s my percentage return over a period of time?” You have to pay out your super liabilities and you’re duration matching.

    In our game, you’ve got this moving benchmark that you’re trying to beat — so sometimes you have to think about… what’s an investment idea that’s going to win in the short term. 

    But these guys are like, “Well, in 10 years time, I’m going to have this liability. And what’s a dependable income stream that I can bank upon to provide that income stream?” 

    So you’ve got this difference in duration. That’s all to say, look, there’s an expectation that there’ll be a higher bid, I would say. We’ll see how that plays out. 

    Obviously, if there’s no higher bid, then it’s likely that the share price will fall from where it’s at, I’m not sure how much. But it’s still an extremely quality asset and I think globally, if we look at the global experience with COVID generally, there’s an acceptance that we’ll get out of this with widespread vaccination. From that perspective, there’s clear long-term value there.

    Hottest ASX shares

    MF: What are the 2 best stock buys right now?

    JK: The two best buys? So I actually struggled with this. One of them started really well, that’s the problem.

    We bought Resmed CDI (ASX: RMD) before this wider Koninklijke Philips NV recall. So I’m not sure how much further upside there is in the short-term. 

    We got in there, the wider recall came out and so we’ve done very well out of that. Now, clearly, the market is well aware of those. 

    I’m not saying we’re going to be selling Resmed because we think there’s this enormous opportunity for them to grab a 20% market share going forward. I think that’s what most people expect. It’s a quality business, we want to see the earnings come through and if they deliver and grab even more share then it’s going to be even more valuable. 

    So one of the companies I wrote about is a little gold mine called Capricorn Metals Ltd (ASX: CMM). Since I wrote about it, it’s actually come off a little bit, but again, this is one of those 6, 12-month investment horizons where they’re just commissioning this new mine in WA called Karlawinda. 

    The management team is top-notch. So the guys are ex-Regis Resources Limited (ASX: RRL). If you look at what Regis did back in 2010 to 2013, 2014, they did a tremendous job generating shareholder value. Generally, there were lower grade gold deposits, but they’re very low-cost operators. It’s very cost-focused, it’s a huge amount of skin in the game.

    These guys have done it in the past. It’s a relatively low-risk project. It’s not so gold price-dependent, but in terms of the investment thesis, it’s very much a re-rate story because once they’re fully up and running, it’ll look very cheap. It’ll generate significant cash flows.

    MF: Because Resmed has already gone up, is there another ‘buy’ you’d like to mention?

    JK: Look, there’s one I really like, this little business called Codan Limited (ASX: CDA). I’m a big fan of that one. Now it’s waiting for the next catalyst. 

    Let’s say it’s got a little bit more integration risk because they bought a couple of businesses in the last 6 months. But if they can get those acquisitions right, get them humming, yeah, there’s a small upside. 

    They’ve got this metal detection division, which is growing extremely well. They’ve seen [a] pickup in volume, they’ve been able to push through price increases and they’re the number 1 player. Their products have better reviews than competitors. They’ve just gone into the recreational side of things. So more coins, et cetera. 

    They’re doing really well. The communications division, which has generally been a bit small, they’ve just gone out and bought 2 businesses to complement their existing business at a reasonable price — which means that if they execute on some of their targets, then you’re looking at a much bigger, more valuable business in the next 6 to 12 months. 

    We won’t know for a little while because they’re just bedding those businesses down. But it’s one that I think is definitely worth watching.

    The post Plumbing, health, tech: 3 ASX shares to buy for instant diversification appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor Tony Yoo owns shares of Sydney Airport Holdings Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Reliance Worldwide Corporation Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended Reliance Worldwide Corporation Limited and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3eZYXxo

  • The Telstra (ASX:TLS) share price is down 35% in 5 years. But have the dividends paid off?

    mathematics, calculator, calculations, maths problem

    The Telstra Corporation Ltd (ASX: TLS) share price has had a poor run over the last few years, but some Telstra shareholders continue to hold the ASX 200 blue chip in the belief its famous dividends are earning sweet profit.

    5 years ago today, the Telstra share price was trading at $5.77. Right now, it’s $3.74.

    That’s 35% lower and means someone who bought a single Telstra share in 2016 would be $2.03 out of pocket today.

    However, many believe that Telstra’s dividends offset any potential loss its share price might experience. But has that been proven over the past 5 years?

    Thankfully, The Motley Fool has done the math to find out if Telstra shareholders are sitting in the green despite the Telstra share price being solidly in the red over 5 years.

    Before we start, it’s worth mentioning many investors see value in Telstra’s dividends regardless of their value for money because of franking credits. In some cases, franking credits can reduce the amount of tax an investor pays.

    Historically, Telstra’s dividends have always been fully franked.

    Have Telstra’s dividends paid off?

    Telstra shares are known for their dividends, and over the years they’ve been relatively reliable.

    In fact, here’s a list of all the dividends Telstra has given its shareholders since the end of the 2016 financial year:

    Dividend payment date Value of dividend
    September 2016 15.5 cents per share
    March 2017 15.5 cents per share
    September 2017 15.5 cents per share
    March 2018 11 cents per share
    September 2018 11 cents per share
    March 2019 8 cents per share
    September 2019 8 cents per share
    March 2020 8 cents per share
    September 2020 8 cents per share
    March 2021 8 cents per share

    The math:

    So, here’s the answer to the age-old (well, five-year-old) question of whether it pays to keep Telstra shares for their dividends.

    If an investor put $10,000 into Telstra shares on 26 July 2016, their holding would be worth around $6481 today. Not a great start…

    However, they would have seen $1.085 worth of dividends per share over the life of their holding.

    5 years’ worth of Telstra dividends (on a $10,000 investment made 5 years ago today) would total roughly $1,880 – not quite the $3,519 this poor fictional investor has lost on their original investment.

    But not all hope is lost. Let’s not forget that Telstra plans to return half the proceeds of a $2.8 billion sale to shareholders this financial year.

    Telstra share price snapshot

    Despite being in the red long term, the Telstra share price is, over the short term, in the green.

    Right now, it is around 24% higher than it was at the start of 2021. It has also gained around 11% since this time last year.

    The post The Telstra (ASX:TLS) share price is down 35% in 5 years. But have the dividends paid off? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Telstra right now?

    Before you consider Telstra, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Telstra wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Corporation Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3i7BAnK

  • Own IAG (ASX:IAG) shares? Here’s what to look for during reporting season

    ASX share price on watch represented by surprised man with binoculars

    Insurance Australia Group Ltd (ASX: IAG) shares have been picking up momentum in recent days. Shares in the Aussie insurance company climbed 2.2% higher on Monday and are up 5.9% in the last 5 days.

    August is looming large right now, and that means the full-year reporting season is nearly upon us. Here are a few things to watch out for if you’re an IAG investor.

    What reporting season could mean for IAG shares

    IAG is the largest general insurance company in Australia and New Zealand. That means investors will be wanting to see signs that are good for the general insurance industry, such as higher premiums, low likelihood of payouts and a clear future strategy.

    It’s worth noting that IAG has already provided its preliminary FY2021 results to the market. IAG shares climbed higher last week following the financial update ahead of the group’s full-year results.

    The Aussie insurer flagged a statutory net loss but claimed many “unusual items”. IAG expects to report gross written premium (GWP) growth of 3.8% with net earned premium up 1.5% on FY2020 to $7,473 million.

    The insurer’s underlying insurance margin is expected to fall 130 basis points to 14.7% with a $427 million reported net loss, down from a $435 million net profit in FY2020.

    However, managing director and CEO Nick Hawkins said the financial results are “sound and within expectations”. COVID-19, additional expenses from a new operating model and losses in New Zealand were all cited as temporary factors weighing on the group’s performance.

    IAG shares will certainly be worth watching in August. The group will release its full-year audited results on 11 August 2021. It may also be worth keeping an eye on other Aussie insurance results for signs of deteriorating conditions such as higher average claims or net natural perils claim costs.

    Suncorp Group Ltd (ASX: SUN) and QBE Insurance Group Ltd (ASX: QBE) are two that spring to mind. Reviewing a cross-section of the Aussie insurance market could help provide insight into the prospects for IAG shares in the year ahead. Analysing financial results and qualitative commentary across these three entities could provide a broader perspective of how the industry is faring going into FY2022.

    Foolish takeaway

    IAG shares have struggled in the last 12 months, edging 0.4% lower to $5.02 per share. However, IAG has already flagged an increase in FY2022 underlying margin which may have investors hoping for a good year ahead.

    Investors will be watching the IAG full-year result commentary closely as well as results from fellow Aussie insurers in August.

    The post Own IAG (ASX:IAG) shares? Here’s what to look for during reporting season appeared first on The Motley Fool Australia.

    Should you invest $1,000 in IAG right now?

    Before you consider IAG, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and IAG wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Insurance Australia Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3BKfcID

  • 2 small cap ASX shares brokers rate as buys

    Big green letters spell growth, indicating share price movements for ASX growth shares

    The small end of the Australian share market is home to a number of companies with the potential to grow materially in the future.

    Two investors might want to get better acquainted with are listed below. Here’s why brokers rate them highly:

    Adore Beauty Group Limited (ASX: ABY)

    The first small cap ASX share to look at is Adore Beauty. It is Australia’s leading online beauty retailer.

    Adore Beauty has been growing strongly during FY 2021 thanks to the shift online. In fact, things have been going so well it recently revealed that it expects to report full year revenue growth of 43% to 47%.

    And while its growth is likely to moderate in FY 2022 as its cycles significantly strong sales growth during the pandemic, its future remains very positive. This is thanks to its leadership position and the structural shift online for beauty sales.

    It is worth noting that online penetration rates for beauty products are still much lower than other categories and in comparison to other Western markets.

    UBS is a fan of Adore Beauty. Its analysts currently have a buy rating and $5.60 price target on the company’s shares.

    Universal Store Holdings Limited (ASX: UNI)

    Another small cap ASX share to look at is Universal Store. It is a fashion retailer delivering an ever-changing and carefully curated selection of on-trend products.

    Thanks to its strong market position and a favourable redirection in consumer spending, Universal Store has been a very positive performer this year. For example, it delivered a 23.3% increase in half year sales to $118 million and a 63.6% increase in underlying net profit after tax to $21.1 million.

    It then followed this up with an even stronger performance in the third quarter. Universal Store reported a 39.6% increase in quarterly sales, putting it in a position to deliver a very strong full year result in August.

    Macquarie is positive on the company. Earlier this month it initiated coverage on the company with an outperform rating and $8.60 price target.

    The post 2 small cap ASX shares brokers rate as buys appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Adore Beauty Group Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/2TB4rXU

  • 2 ASX shares that many brokers think could be buys

    ASX shares upgrade buy Woman in glasses writing on buy on board

    There are a small number of ASX shares that many brokers like at the same time.

    It might indicate that there is an opportunity with these businesses because brokers are constantly on the lookout for ideas. If they all like a company, then perhaps it’s an obvious idea. Or maybe they’re all wrong at the same time. Only time will tell.

    Here are two of those businesses:

    Credit Corp Group Limited (ASX: CCP)

    Credit Corp is a large debt collector in Australia and it has quickly-growing US operations as well.

    It’s currently rated as a buy by at least three brokers. One of the brokers that likes Credit Corp is Morgans, which has a price target of $33.45 on the business. That suggests the Credit Corp share price could rise by more than 15% over the next 12 months.

    The broker is expecting a strong profit result when Credit Corp reveals its FY21 report. It also thinks there is more PDL (purchased debt ledger) growth to come over the next 12 months. The US presents a good chance to increase its penetration in that market.

    At the end of April 2021, the business gave an update. It suggested that it’s expecting a return to its pre-COVID growth trajectory of net profit and with its return on assets (ROA).

    This growth could be delivered despite challenging debt buying market conditions, with a temporary reduction in market sale volumes of around 50% in both the domestic markets and the US.

    However, at the time of the update, there were early indications of a recovery in sales volumes for the ASX share. A major Australian bank’s forward flow volume was up 50% on the run rate in April. There had also been a strong US credit growth rebound.

    Credit Corp says that it has the capacity to increase investment as opportunities arise with cash and undrawn lines of around $400 million. It’s already the sixth largest debt buyer in the US market.

    Current FY21 net profit guidance is for a range of between $85 million to $90 million.

    Monash IVF Group Ltd (ASX: MVF)

    Monash IVF is another ASX share that is liked by several brokers. It’s a business that specialises in fertility treatments. It is rated as a buy by the broker Macquarie Group Ltd (ASX: MQG) which has a price target of $1 on the business. That suggests it could rise by around 15% over the next 12 months, if Macquarie is right.

    Macquarie thinks things could turn around for Monash with more fertility activity expected. Research and development spending could help it achieve better success rates over time.

    In the FY21 half-year result, Monash IVF said that it made $14.6 million of statutory profit, up 78.5% year on year. Underlying net profit was $12 million, up 32%.

    The first six months of FY21 saw Australian stimulated cycle growth of 27.4% thanks to the pent-up demand that was created during the temporary suspension of services in the final quarter of FY21. In the second quarter it saw cycle growth of 33.1% because of national industry growth of 20.6% and market share gains in Victoria, NSW and Queensland.

    Monash IVF also said that solid progress is being made in southeast Asia with its expansion plans. There was 6.6% growth of Kuala Lumpur stimulated cycles.

    The ASX share recommenced dividends, with improved operating cashflow generation. Management also said that the balance sheet is well positioned for future organic growth. The balance sheet can support strategic infrastructure projects according to the company.

    The post 2 ASX shares that many brokers think could be buys appeared first on The Motley Fool Australia.

    Should you invest $1,000 in right now?

    Before you consider , you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3eYgzd3

  • Could it be time to consider buying Afterpay (ASX:APT) shares?

    New ASX share buy ideas

    The Afterpay Ltd (ASX: APT) share price certainly knows how to keep investors guessing. This buy now, pay later (BNPL) pioneer has had one of the most intense rollercoaster rides of any company on the S&P/ASX 200 Index (ASX: XJO) over the past 18 months or so. To illustrate, let’s go back to February 2020, just prior to the onset of the global pandemic.

    In February 2020, Afterpay was riding high at its (then) all-time high of around $38 per share. Following the February/March market crash, things turned very bad, very fast. The Afterpay share price dropped like a stone, falling as low as $8 by the market bottom on 23 March. That was a fall of more than 70%.

    But Afterpay subsequently recovered even faster. By early May, it was back to its pre-COVID levels, and by August, it had doubled them. 

    The revelation that e-commerce giant Tencent Holdings had taken a 5% stake in Afterpay was the real catalyst here. But it also helped that a predicted recession-induced wave of BNPL defaults had failed to materialise.

    The company continued to post record growth numbers across the United States and United Kingdom markets, and by February 2021, Afterpay had reached an all-time high of $160.05 per share. Yep, in under a year, this company may have given some investors a return of more than 1,800%. Yikes.

    But that was then, and this is now. There’s no point in crying over spilled shares. So where to for Afterpay shares in July 2021? The company’s shares closed at $104.43 apiece yesterday, a good 35% from their February all-time high.

    Afterpay share price: buy now and get paid later?

    One broker who is bullish on Afterpay shares from here is Morgan Stanley. As my Fool colleague James covered last week, Morgan Stanley currently rates Afterpay shares as ‘overweight’, with a 12-month share price target of $145 for the BNPL company. The broker is reportedly bullish on the company’s new Money by Afterpay app, which it believes has the potential to double its Australian revenues. 

    It’s not just Morgan Stanley either. My fellow Fool colleague Brendon has also recently discussed broker Macquarie‘s ‘buy’ rating on Afterpay as well.

    At Afterpay’s closing share price of $104.43 yesterday, the company has a market capitalisation of $30.25 billion. 

    The post Could it be time to consider buying Afterpay (ASX:APT) shares? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Afterpay right now?

    Before you consider Afterpay, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Afterpay wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended AFTERPAY T FPO. The Motley Fool Australia owns shares of and has recommended AFTERPAY T FPO and Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3zAjdh1

  • 3 stellar ASX growth shares that could be buys in August

    A man with a yellow background makes an annoncement, indicating share price changes on the ASX

    If you’re planning to add some growth shares to your portfolio in August, then you might want to look at the shares listed below.

    All three of these ASX growth shares have been tipped as buys recently. Here’s what you need to know about them:

    Hipages Group Holdings Ltd (ASX: HPG)

    The first ASX growth share to look at is Hipages. It is a leading Australian-based online platform and software as a service (SaaS) provider. The Hipages platform connects consumers with trusted tradies to simplify home improvement. At the last count, there were over 34,000 tradies using the platform.

    Analysts at Goldman Sachs are very bullish on the company’s prospects. The broker believes it has a huge growth runway ahead as its ecosystem builds. Goldman has a buy rating and $4.10 price target on its shares.

    Nitro Software Ltd (ASX: NTO)

    Another growth share to look at is Nitro Software. It is a software company that is aiming to drive digital transformation in organisations around the world. Its key solution is the Nitro Productivity Suite, which provides integrated PDF productivity and electronic signature tools to customers. Demand has been growing rapidly in recent years and has continued in FY 2021. This is underpinning strong recurring revenue growth and should be boosted by a recent acquisition and integration with Salesforce.

    Morgan Stanley is positive on the company. Its analysts currently have an overweight rating and $3.70 price target on Nitro’s shares.

    PointsBet Holdings Ltd (ASX: PBH)

    A final growth share to look at is PointsBet. It is a sports wagering operator and iGaming provider with operations in the ANZ and US markets. PointsBet has been growing at a rapid rate thanks to the increasing popularity of mobile sports betting and innovative new products. Pleasingly, its growth is only really getting started. This is particularly in the case in the United States where regulation changes are creating huge opportunities.

    Goldman Sachs is a big fan of PointsBet due to its massive opportunity in the United States. The broker is tipping the company to grow very strongly during the 2020s. As a result, Goldman currently has a buy rating and $17.20 price target on its shares.

    The post 3 stellar ASX growth shares that could be buys in August appeared first on The Motley Fool Australia.

    Should you invest $1,000 in PointsBet right now?

    Before you consider PointsBet, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and PointsBet wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Hipages Group Holdings Ltd. and Pointsbet Holdings Ltd. The Motley Fool Australia has recommended Nitro Software Limited and Pointsbet Holdings Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/2WiNAdj

  • Should you buy Medibank (ASX: MPL) shares in July for the dividend?

    patient with doctor, medical company, medical insurance

    Should you consider the Medibank Private Ltd (ASX: MPL) share price in July 2021 for the dividend yield?

    Private health insurance giant Medibank has amassed a reputation as a heavyweight ASX dividend share ever since its 2014 transition from government-owned entity to public company.

    In fact, the company had been steadily ramping up its dividend payments until the coronavirus crisis came to our shores last year. From 2015 until 2019, Medibank increased its dividend payouts every single year like clockwork.

    But Medibank was indeed forced to trim its payouts last year. In 2019, the company paid out three dividends. These consisted of a single interim payment of 5.7 cents per share, and a final and special dividend of 7.4 cents and 2.5 cents per share respectively.

    What kind of dividends are Medibank shares offering today?

    In 2020, Medibank kept its March interim dividend at 5.7 cents. However, it was forced to trim its September final dividend down to 6.3 cents per share.

    In 2021 so far, the company has paid an interim dividend of 5.8 cents per share. That’s a slight bump to its last two interim dividends.

    These dividend payments give Medibank shares a trailling yield of 3.64% on current pricing. That rises to 5.21% grossed-up with the company’s usual full franking.

    It’s not yet certain what Medibank’s final dividend will look like when it gets delivered to shareholders’ bank accounts in September this year. But investment bank Goldman Sachs has a prediction.

    Goldman estimates Medibank will pay out 12.6 cents per share in dividends for FY21, which means it is anticipating a final dividend of 6.8 cents per share. That would give Medibank shares a forward yield of 3.81% on current pricing.

    Further, in some good news for those income investors who appreciate a steadily rising dividend, Goldman is predicting Medibank will be able to resume its pattern of annual dividend increases. It anticipates the company’s dividend will reach 13.3 cents per share by FY2023.

    It’s worth noting that Goldman currently has a ‘neutral’ rating on the Medibank share price. With a 12-month price target of $3.34 a share, that’s just 0.9% above the share price Medibank closed at yesterday.

    At this share price, Medibank has a market capitalisation of $9.14 billion, with a price-to-earnings (P/E) ratio of 25.34.

    The post Should you buy Medibank (ASX: MPL) shares in July for the dividend? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Medibank Private right now?

    Before you consider Medibank Private, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medibank Private wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3BJyTjS

  • Why has the Brickworks share price rocketed up 50% in the last year?

    asx share investor climbing up stairs of an upward trending graph

    The Brickworks Limited (ASX: BKW) share price has gone up more than 50% over the last year.

    Brickworks is a diversified property business. It has a number of building products such as bricks, roofing and precast. But the company also has investments including a 50% stake of a joint venture trust with Goodman Group (ASX: GMG) and its holding of Washington H. Soul Pattinson and Co. Ltd (ASX: SOL) shares.

    The business has experienced growth in all areas.

    Soul Patts experiences share price growth

    Brickworks owns a 39.4% stake in Soul Patts, which has a diversified portfolio of investments in listed and unlisted companies. Major investments include Brickworks, TPG Telecom Ltd (ASX: TPG), New Hope Corporation Limited (ASX: NHC) and Australian Pharmaceutical Industries Ltd (ASX: API).

    In the first half of FY21, Brickworks’ shareholding of Soul Patts increased by $720 million. Over the last 12 months, the Soul Patts share price has risen by around 65%.

    Soul Patts announced on 22 June 2021 that it plans to take over the listed investment company (LIC) Milton Corporation Limited (ASX: MLT). The Soul Patts share price has increased by more than 9% since that announcement.

    Property Trust

    In June, Brickworks said that it’s expecting to report record property earnings in FY21, with property earnings before interest and tax (EBIT) of between $240 million to $260 million, driven by the continued increase in the value of its property trust.

    Management explained that it has seen strong demand and sustained growth in the value of its property trust over a number of years. The COVID-19 pandemic has fuelled this growth, by accelerating industry trends towards online shopping and increasing the importance of well-located distribution hubs and sophisticated supply chain solutions.

    Brickworks said that as a result of sales and an increase in transaction pricing, and an independent valuation of its property trust assets, the joint venture saw a revaluation profit of around $100 million which will be recorded in the second half. This represented Brickworks’ half of the valuation gain.

    Practical completion of the Amazon facility at Oakdale West is expected to occur in the first half of FY22. The even larger Coles Group Ltd (ASX: COL) distribution warehouse is under construction, with completion expected in early FY23.

    Building products

    When it released its trading update, Brickworks said that it was seeing sales momentum in both Australia and North America.

    In local currency terms, it’s expecting a higher EBIT from both the North American and Australian building product divisions. In Australia, sales were particularly strong in Queensland and Western Australia, but the availability of some materials were causing delays.

    In the US it was seeing a strong rebound in sales volumes to housing customers in May. A strengthening of commercial sales was anticipated as delayed and deferred projects re-commence.

    Brickworks share price

    Brickworks has seen all of its divisions benefit over the last year as they recover and grow.

    Citi currently rates Brickworks as a buy with a price target of $27.20.

    The post Why has the Brickworks share price rocketed up 50% in the last year? appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of May 24th 2021

    More reading

    Motley Fool contributor Tristan Harrison owns shares of Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Brickworks, COLESGROUP DEF SET, and Washington H. Soul Pattinson and Company Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3zDqI6J